Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited will hold a board meeting on Wednesday, August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing on August 4, 2026. The trading window for the company's securities, which was closed on July 1, 2026, will reopen 48 hours after the financial results are declared.

Suraksha Diagnostic announced that the 21th Annual General Meeting(AGM) of the company will be held on 2 September 2026.

Suraksha Diagnostic announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Suraksha Diagnostic Ltd lost 7.95% today to trade at Rs 294.5. The BSE Healthcare index is down 0.51% to quote at 47612.76. The index is up 9.48 % over last one month. Among the other constituents of the index, Max Healthcare Institute Ltd decreased 5.18% and Aurobindo Pharma Ltd lost 3.54% on the day. The BSE Healthcare index went up 11.99 % over last one year compared to the 7.03% fall in benchmark SENSEX. Suraksha Diagnostic Ltd has added 4.27% over last one month compared to 9.48% gain in BSE Healthcare index and 4.15% drop in the SENSEX. On the BSE, 1019 shares were traded in the counter so far compared with average daily volumes of 3298 shares in the past one month. The stock hit a record high of Rs 353.65 on 26 Jun 2025. The stock hit a 52-week low of Rs 224.1 on 30 Mar 2026.Powered by Capital Market - Live

Net profit of Suraksha Diagnostic declined 15.02% to Rs 6.28 crore in the quarter ended March 2026 as against Rs 7.39 crore during the previous quarter ended March 2025. Sales rose 25.07% to Rs 81.41 crore in the quarter ended March 2026 as against Rs 65.09 crore during the previous quarter ended March 2025. For the full year,net profit rose 1.16% to Rs 32.19 crore in the year ended March 2026 as against Rs 31.82 crore during the previous year ended March 2025. Sales rose 23.13% to Rs 310.41 crore in the year ended March 2026 as against Rs 252.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales81.4165.09 25 310.41252.09 23 OPM %29.9229.47 -30.7332.23 - PBDT21.2417.94 18 86.0176.70 12 PBT9.989.21 8 44.5641.41 8 NP6.287.39 -15 32.1931.82 1 Powered by Capital Market - Live

Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 21 May 2026.

The key equity benchmarks traded with substantial losses in the mid-afternoon trade adopted a risk-off approach amid escalating geopolitical tensions following the US-Israel attacks on Iran. Traders are closely monitoring crude oil and metal prices. The Nifty slipped below the 24,800 level, reflecting weak market sentiment. Media shares declined after advancing in the past trading session. At 14:25 IST, the barometer index, the S&P BSE Sensex tanked 1,351.91 points or 1.66% to 79,911.22. The Nifty 50 index tumbled 420.15 points or 1.67% to 24,762.05. In the broader market, the BSE 150 MidCap Index declined 1.79% and the BSE 250 SmallCap Index slipped 2.32%. The market breadth was negative. On the BSE, 612 shares rose and 3,688 shares fell. A total of 167 shares were unchanged. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rallied 27.23% to 17.44. Buzzing Index: The Nifty Media index fell 2.22% to 1,386.25. The index advanced 0.60% in the past trading session. Hathway Cable & Datacom (down 5.13%), Zee Entertainment Enterprises (down 4.38%), D B Corp (down 3.89%), Nazara Technologies (down 3.53%), Sun TV Network (down 3.4%), Network 18 Media & Investments (down 2.55%), Saregama India (down 2.39%), Tips Music (down 2.27%), PVR Inox (down 1.79%) declined. US-Iran Conflict: The United States and Israel have launched major coordinated military strikes on Iran, marking a significant escalation in long-running Middle East tensions. On 1 March 2026, Iran launches missile and drone strikes on U.S. bases across six Middle Eastern countries amid escalating military tensions. Iran's Supreme Leader Ayatollah Ali Khamenei was reportedly killed in the attacks, escalating tensions further. Following his death, Iran appointed Ayatollah Alireza Arafi to its interim leadership council, which will assume charge of the country's affairs. Numbers to Track: The yield on India's 10-year benchmark federal paper rose 0.54% to 6.697 compared with the previous session close of 6.661. In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 91.4700 compared with its close of 91.0800 during the previous trading session. MCX Gold futures for 2 April 2026 settlement gained 4.23% to Rs 168,950. The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.83% to 98.42. The United States 10-year bond yield jumped 0.18% to 3.965. In the commodities market, Brent crude for May 2026 settlement surged $6.21 or 8.52% to $79.08 a barrel. amid heightened geopolitical tensions. According to media reports, Saudi Arabia's state-owned oil major Aramco temporarily shut down its Ras Tanura refinery on Monday as a precautionary measure after an Iranian drone strike reportedly sparked a fire at the facility. Stocks in Spotlight: Suraksha Diagnostic fell 2.06% after its group chief financial officer (CFO) and key managerial personnel (KMP), K S Ravindra, has tendered his resignation due to personal reasons. The company said Ravindra will step down from his role on or before 31 May, 2026, close of business hours.Powered by Capital Market - Live

The company said Ravindra will step down from his role on or before 31 May, 2026, close of business hours. In his resignation letter, Ravindra confirmed that there are no material reasons for his decision other than those stated. The diagnostics services provider clarified that disclosures relating to appointment of director and relationship between directors are not applicable in this case, as the resignation pertains solely to the CFO position. The company did not immediately announce a successor. Suraksha Diagnostic offers integrated pathology and radiology testing, along with medical consultancy services. The company had reported a 21% rise in consolidated net profit to Rs 7.24 crore on a 30.5% increase in total revenue from operations to Rs 77.69 crore in Q3 FY26 as compared with Q3 FY25.Powered by Capital Market - Live

Net profit of Suraksha Diagnostic rose 22.28% to Rs 7.52 crore in the quarter ended December 2025 as against Rs 6.15 crore during the previous quarter ended December 2024. Sales rose 30.55% to Rs 77.69 crore in the quarter ended December 2025 as against Rs 59.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales77.6959.51 31 OPM %29.8130.68 - PBDT20.6216.87 22 PBT10.068.05 25 NP7.526.15 22 Powered by Capital Market - Live

Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live